Delivery Order SPE2DB20D1100-SPE2DB24FD7U5

Award Date 9/11/24
Potential Completion Date 9/12/24
Potential Value $1.8K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of Hydrocort-Pramoxine 1%-1% Cream, 30 grams, with a ceiling value of $1,724.46 and a completion date of April 15, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) held by...
This is a $1,434.24 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Hydrocortisone-Pramoxine 2.5-1% cream. The order has a completion date of September 18, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical through December 2025 for delivering a wide range of medical commodities to support military...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,223.10 firm fixed-price contract is for the supply of Hydrocort-Pramoxine 2.5-1% Cream, 30 grams, with a period of performance through November 19, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $61,215.57, is for the delivery of Hydrocort-Pramoxine 2.5-1% cream, which is a pharmaceutical product used for medical treatment. The contract has a completion date of May 10, 2024 and is a firm fixed-price delivery order. This contract is not associated with any set-aside designation, indicating that it was...
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,127.28, is for the delivery of Hydrocort-Pramoxine 1%-1% Cream (30g) and has an ultimate completion date of January 30, 2025. Amerisourcebergen is the prime contractor, and there is no set-aside designation mentioned. The contract is a firm-fixed-price delivery order,...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,117.71 firm fixed-price contract is for the supply of Hydrocort-Pramoxine 1%-1% cream, a topical pharmaceutical product, with a completion date of January 23, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation, to provide 453.6 grams of 1% hydrocortisone cream. The $1,219.04 order has a completion date of January 30, 2024 and was awarded on January 29, 2024. Amerisourcebergen Drug Corp is the prime contractor on this order, which does not have a set-aside designation. This delivery order is part of an indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,815.25 delivery order contract is for the supply of Hydrocort-Pramoxine 2.5-1% Cream, a pharmaceutical product. The contract has an ultimate completion date of August 18, 2022 and is a firm fixed-price delivery order. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,834.51 firm fixed-price contract is for the supply of Hydrocortisone-Pramoxine 2.5-1% cream, a topical medication. The contract has an ultimate completion date of November 1, 2023 and was awarded on October 31, 2023. There was no set-aside designation, indicating the contract was open to full and open competition....
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of a medical product, "HYDROCORT-PRAMOXINE 2.5-1% CRM 30GM." The contract, valued at $4,424.93, has an ultimate completion date of April 8, 2024. This delivery order is issued under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, which has a potential value of...
  • SPE2DB20D1100
    Indefinite Delivery Contract
  • SPE2DB20D1100-SPE2DB24FD7U5
    Delivery Order

This is a delivery order issued by the Defense Logistics Agency (DLA) under an Indefinite Delivery Contract (IDC) with AmerisourceBergen Drug Corporation to supply a pharmaceutical product - Hydrocort-Pramoxine 1%-1% Cream in 30-gram tubes. The delivery order has a ceiling value of $1,820.31 and a completion date of September 12, 2024. The contract is a firm-fixed-price arrangement. AmerisourceBergen, a major pharmaceutical distributor, has been awarded this delivery order as well as multiple other IDCs by various federal agencies, including the Department of Justice Federal Bureau of Investigation, to provide a diverse range of medical commodities and prescription drugs to support the healthcare needs of military personnel, veterans, and other federal beneficiaries.

Generated 12/11/24, 9:32 AM